Canagliflozin
SGLT2 & Metformin
$143.70 ~
Vokanamet 50/1000mg is an original dual-action medication manufactured by Johnson & Johnson Pvt...
Vokanamet 50/1000mg is an original dual-action medication manufactured by Johnson & Johnson Pvt Ltd. It combines Canagliflozin (50mg), an SGLT2 inhibitor, with Metformin (1000mg), a biguanide, to deliver comprehensive management of type 2 diabetes mellitus.
Canagliflozin reduces glucose reabsorption in the kidneys, increasing urinary glucose excretion, while Metformin decreases hepatic glucose production and improves insulin sensitivity. Together, they provide superior glycemic control and deliver additional cardiovascular and renal benefits, making this therapy particularly valuable for patients at risk of heart or kidney complications.
Beyond blood sugar regulation, Vokanamet 50/1000mg also supports weight management and overall metabolic health, positioning it as an essential treatment option for lifestyle-related diseases.
